Evidence map›Paper›PMID 31681285›Full record

ArticleFrontiers in immunology2019

Augmented Brain Infiltration and Activation of Leukocytes After Cerebral Ischemia in Type 2 Diabetic Mice.

Fang Zhang, Qiuchen Zhao, Yinghua Jiang, Ning Liu, Qiang Liu, Fu-Dong Shi, Junwei Hao, Yun Xu, Eng H Lo, Xiaoying Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. First-in-human dosimetry and biodistribution of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Inflammatory Responses After Ischemic Stroke.Seminars in immunopathology · 2022
    Review
  12. Article
  13. Article
  14. Macrophage, a potential targeted therapeutic immune cell for cardiomyopathy.Frontiers in cell and developmental biology · 2022
    Review
  15. The Alteration Profiles of mFrontiers in neuroscience · 2022
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Fang ZhangNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Qiuchen ZhaoNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Yinghua JiangNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Ning LiuNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Qiang LiuBarrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, United States.
Fu-Dong ShiDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
Junwei HaoDepartment of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
Yun XuDepartment of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
Eng H LoNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Xiaoying WangNeuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Harvard University · USTianjin Medical University General Hospital · CNTulane University · USMassachusetts General Hospital · USNanjing Drum Tower Hospital · CNSt. Joseph's Hospital and Medical Center · US

Funding

Recombinant FGF21 as a novel approach for treating ischemic stroke in type 2 diabetesR01NS099539 · NINDS · TULANE UNIVERSITY OF LOUISIANA · PI WANG, XIAOYING · 2016 to 2020
$1.8M
NINDS NIH HHS R01 NS099539
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrainBrain IschemiaDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2HumansLeukocytesMiceStrokedb/db type 2 diabetes micediabetes mellitusdistal middle cerebral artery occlusionimmune systemischemic strokeleukocyte brain infiltrationleukocyte mobilization

Identifiers

PMID31681285
PMCPMC6797587
OpenAlexW2980262163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.